Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.12NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.12ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BM.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BM.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
BM.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BM.3ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BM.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BM.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BM.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
BM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BM.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BM.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BM.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BM.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.5.2.28ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.5.2.28ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.5.2.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.28ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.28ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.28ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.5.2.28ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.5.2.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.28SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.28SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.28NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BA.5.2.28NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.5.2.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.28NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.28NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.2.28NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.28ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.5.2.62ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used